Full Text (PDF)
Original Article

Novel Approach of Stability Indicating Method Development for Determination of Metformin and Empagliflozin by High Performance Liquid Chromatography

A Sai Datri, A Lakshmana Rao, Ch Purna Durganjali

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

 This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Journal of Pharmaceutical and Medicinal Chemistry 8(2):p 53-61, July-December 2022. | DOI: https://doi.org/10.21088/jpmc.2395.6615.8222.1

How Cite This Article:

A Sai Datri, A Lakshmana Rao, Ch Purna Durganjali/Novel Approach of Stability Indicating Method Development for Determination of Metformin and Empagliflozin by High Performance Liquid Chromatography/ J Pharmaceut Med Chem. 2022;8(2):53-61.

Timeline

Received : March 09, 2022         Accepted : June 10, 2022          Published : December 25, 2022

Abstract

A simple, accurate, precise RP-HPLC method was developed for the simultaneous estimation of the Metformin and Empagliflozin in the tablet dosage form. Materials and Methods: Chromatogram was run through Std Agilent 18 (150 x 4.6mm, 5μm). Mobile phase taken as 0.1% OPA Buffer: Acetonitrile in 60:40% v/v ratio, and pumped through the column at a flow rate of 1mL/min. The buffer used in this method was 0.1% OPA buffer. The temperature was maintained at 25°C. Results and Discussion: Optimized wave length selected was 245 nm. The retention times of Metformin and Empagliflozin were found to be 2.193 min and 2.668 min respectively. %RSD of the Metformin and Empagliflozin was found to be 1.4 and 0.8 respectively. % Recovery was obtained as 99.66% and 100.24% for Metformin and Empagliflozin respectively. LOD, LOQ values obtained from regression equations of Metformin and Empagliflozin were 0.02, 1.48, and 0.05, 4.93 respectively. Regression equation of Metformin is y =20952x + 9914.5 and y = 41842x + 571.79 of Empagliflozin. Retention times were decreased and that run time was decreased, The Reverse Phase HPLC isocratic method for Metformin and Empagliflozin is developed and validated as per ICH guidelines. Conclusion: The test method is found to be sensitive, accurate, precise, linear, convenient, and economical that can be adopted in regular quality control tests in Industries.


References

  • 1.   http://www.drugbank.ca/drugs/DB00331.
  • 2.   http://www.drugbank.ca/drugs/DB0903832.
  • 3.   Mahammad Noorulla1 SK and Sadath Ali. RPHPLC Method Development and Validation for the Simultaneous Estimation of Metformin and Empagliflozin in Tablet Dosage Form. International Journal of Engineering Technology and Sciences. 2015; 11(2): 516-521.
  • 4.   Syed Irfan Ali and Bharath Rathna Kumar P. Stability Indicating Simultaneous Estimation of Metformin and Empagliflozin in Pharmaceutical Tablet Dosage Form by RP-HPLC. International Journal of Life Sciences and Review. 2017; 3(9):92- 99.
  • 5.   Godasu SK and Sreenivas SA. A New Validated RP-HPLC Method for the Determination of Metformin Hcl and Empagliflozin in its Bulk and Pharmaceutical Dosage Forms. International Journal of Pharmaceutical Sciences and Research. 2016; 8(5):2223-32.
  • 6.   Vinay Kumar D and Seshagiri Rao J.V.L.N. A New Validated Stability Indicating RP-HPLC Method for Simutaneous Estimation of Metformin Hydrochloride and Empagliflozin in Tablet Dosage Forms. International Research Journal of Pharmacy and Medical Sciences. 2018; 1(5): 16-22.
  • 7.   Madana Gopal N and Sridhar C. A Validated Stability Indicating Ultra Performance Liquid Chromatographic Method for Simultaneous Determination of Metformin Hydrochloride and Empagliflozin in Bulk Drug and Tablet Dosage Form. International Journal of Applied Pharmaceutics. 2017; 9(3): 45-50.
  • 8.   ICH Harmonised Tripartite Guideline, Validation of analytical procedures: Text and methodology, Q2(R1), International Conference on Harmonization, Geneva. 2005; 1-13.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

A Sai Datri, A Lakshmana Rao, Ch Purna Durganjali/Novel Approach of Stability Indicating Method Development for Determination of Metformin and Empagliflozin by High Performance Liquid Chromatography/ J Pharmaceut Med Chem. 2022;8(2):53-61.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

 This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
March 09, 2022 June 10, 2022 December 25, 2022

DOI: https://doi.org/10.21088/jpmc.2395.6615.8222.1

Keywords

MetforminEmpagliflozinRP-HPLCValidation

Article Level Metrics

Last Updated

Monday 07 September 2026, 22:17:11 (IST)


1017

Accesses

3
100
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received March 09, 2022
Accepted June 10, 2022
Published December 25, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

 This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share